Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fixed dose combination of cannabinoids and medical mushrooms for prevention and treatment of cancer, inflammatory or immune-mediated inflammatory diseases

Fixed dose combination of cannabinoids and medical mushrooms for prevention and treatment of cancer, inflammatory or immune-mediated inflammatory diseases

US Patent 12453750 · Granted Oct 28, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions comprising thymoquinone and omega-3 fatty acids2022
Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamine2022
Stimulant abuse-deterrent compositions2021
Compositions comprising melatonin2020
Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamine2018
Extended release formulations of rasagiline and uses thereof2018
Pharmaceutical compositions for treatment of Parkinson's disease2016
SPG stimulation2016
Pharmaceutical compositions for treatment of Parkinsons disease2015
Neuroprotective electrical stimulation2015
Post-acute electrical stimulation treatment of adverse cerebrovascular events2013
Stimulation for treating brain events and other conditions2011